Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Jacobio Pharmaceuticals Co. Ltd.

http://en.jacobiopharma.com

Latest From Jacobio Pharmaceuticals Co. Ltd.

Breaking Away From Betta, Jacobio Raises China Oncology Development Bar

Emerging Company Profile: Founded by former executives of China’s national innovation darling Betta Pharma, Beijing-based Jacobio is focused on novel oncology assets, led by a KRAS inhibitor that's set to begin Phase I and IIa studies in the US and China for solid tumors.

StartUps and SMEs Cancer

Venture Funding Deals: Atreca Raises $125m To Advance Solid Tumor Candidate

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced August and September.

Deals Financing

Finance Watch: Three New Funds, Including Former Amgen R&D Head Harper's Next Venture

Private Company Edition: Westlake Village BioPartners launched with $320m and Harper as a managing director; UK-based Ahren unveiled a $100m-plus "deep science" fund; and UCSD partnered with Deerfield to finance drug programs. In new financings, Allogene leads with $120m.

Financing StartUps and SMEs
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Immune Disorders
  • Infectious & Viral Diseases
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • China
  • Company Type
  • Start-Up
  • Parent & Subsidiaries
  • Jacobio Pharmaceuticals Co. Ltd.
  • Senior Management
  • Yinxiang Wang, PhD, Chmn. & CEO
    Hu Shaojing, PhD, Pres., R&D
  • Contact Info
  • Jacobio Pharmaceuticals Co. Ltd.
    Phone: 010-56315466
    Bldg. F2, No. 88, Kechuang 6th St.
    Beijing,
    China
Advertisement
Advertisement
UsernamePublicRestriction

Register